ReviewFrontiers in physiology2026

Bioactive compounds as therapeutic modulators of metabolic syndrome: targeting inflammation and gut microbiota regulation.

Magdalene Eno Udobi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.